Press "Enter" to skip to content

New patent for Sanofi Aventis drug AUBAGIO

0
Copyright © DrugPatentWatch. Originally published at New patent for Sanofi Aventis drug AUBAGIO

Annual Drug Patent Expirations for AUBAGIO
Annual Drug Patent Expirations for AUBAGIO

Aubagio is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for AUBAGIO.

This drug has seventy-one patent family members in forty-six countries.

The generic ingredient in AUBAGIO is teriflunomide. One supplier is listed for this compound. Additional details are available on the teriflunomide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Sanofi Aventis drug AUBAGIO
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions